Yamada, Hideyasu
Matsumoto, Isao
Makita, Naoyuki
Arita, Yoshifumi
Hayashi, Nobuya
Mitsuoka, Kurena
Tashiro, Naoki
Hizawa, Nobuyuki
Funding for this research was provided by:
AstraZeneca
Article History
Received: 26 July 2022
Accepted: 8 September 2022
First Online: 19 September 2022
Change Date: 7 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12931-022-02219-y
Declarations
:
: The study protocol was approved by the NPO-MINS Institutional Review Board (Approval No. MINS-REC-210216) in 2021. The study was conducted in accordance with the Ethical Guidelines for Biomedical Research Involving Human Subjects, the ethical principles of the Declaration of Helsinki, and all relevant regulations applicable to noninterventional studies. The requirement for informed consent was waived because the available data in the RWD database were standardized and anonymized.
: Not applicable.
: HY has received honoraria from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, and Novartis. IM, NM, YA, NH, KM, and NT are employees of AstraZeneca K.K. NHi has received honoraria from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, KYORIN Pharmaceutical, Novartis, and Sanofi.